Should you sell Target Corporation or reduce the position?
Calculate what you would remove, what you would retain, and which assumptions support continuing to own it.
Price as of Nov 1, 2026, 3:15 AM UTC (polygon last daily bar) · Evidence through Oct 12, 2026
What has changed in the case for owning it?
Market Ontology's model values Target Corporation at $107.36 per share against $154.38 (-30.5%). 7 dated developments in the last 45 days reach the position.
| Development | Evidence | Assumption affected | Consequence for the case |
|---|---|---|---|
| Oct 12, 2026 · Symbotic Backlog Reaches $22.5B on Enterprise Supply Chain Automation Commitments | 1 source | long-term operating margin improvement through supply chain modernization | Supports the case for owning |
| Sep 27, 2026 · Target Marks 3.8% Comp Sales Growth as 55-Year Dividend Track Record Holds | 1 source | operating margin resilience from 3.8% comparable sales growth | Supports the case for owning |
| Sep 22, 2026 · Target Deploys AI Tools with OpenAI and Google Gemini for Retail Commerce | 1 source | digital conversion rate expansion lifting e-commerce retail margins | Supports the case for owning |
| Sep 22, 2026 · Target Partners with OpenAI and Google on Agentic Retail Commerce | 1 source | digital conversion margin enhancement and GMV growth | Supports the case for owning |
| Sep 22, 2026 · Target Partners with OpenAI and Google Gemini for Agentic Commerce | 1 source | digital conversion rate improvement lifting e-commerce gross margins | Supports the case for owning |
What changes if you sell?
| Keep current position | Sell selected quantity | Exit position | |
|---|---|---|---|
| Shares remaining | 100 | 50 | 0 |
| Estimated proceeds after included transaction costs | — | $7,715 | $15,430 |
| Downside case ($66.49) outcome | −$8,789 | −$4,395 | $0 |
| Upside case ($176.04) outcome | $2,166 | $1,083 | $0 |
| Remaining exposure | $15,438 | $7,719 | $0 |
Included costs: an assumed 5 bps for commission and spread. Tax treatment: not calculated; cost basis is not used in this comparison.
Undecided: sale proceeds and remaining exposure are calculated; replacement performance is left unresolved.
What would justify keeping the remaining position?
- Revenue growth (yr 1) holds near -1.34%: Trailing 4-year revenue CAGR of -1.3%, faded toward terminal growth over 5 years.
- Operating margin (steady-state) holds near 4.74%: Anchored to mean operating margin of 4.7% across the last 4 reported periods.
- Discount rate (WACC) holds near 6.43%: CAPM baseline: 4.98% risk-free + β0.26 × 5.5% ERP = 6.43%.
What would justify investigating it again after an exit?
- Implied revenue growth (next yr → terminal) moves relative to 13.33%: Growth rate that reconciles the current share price to a 5y DCF holding margin, WACC and terminal g fixed.
- Implied steady-state FCF margin moves relative to 3.18%: FCF margin the market needs to justify the current price at modeled growth and WACC.
- The price falls below the downside value of $66.49.
Preserve the reasoning behind the sale.
Save the reduction you're considering, the evidence behind it, and your conditions for reviewing the remaining position. If you exit, keep the research and specify what would justify revisiting TGT.
Should I buy?Should I hold?Should I hedge?How to hedgeImpact ledger